Gufic Biosciences Limited

Gufic Biosciences Limited

Performance

Today's Low Today's High
437.50 438.45
457.00 457.45
52 Week Low 52 Week High
277.65 (15-Mar-2024) 278.00 (04-Jun-2024)
504.25 (08-Nov-2024) 501.10 (08-Nov-2024)

Open
444.30 444.60
Previous Close
440.95 441.25
Volume
0.82
Total Traded value
3.69 (₹ Lakhs)
Upper circuit
529.10 425.15
Lower circuit
352.80 283.45

Market Depth

Buy Order Quantity Sell Order Quantity
0
21

Bid PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--
Ask PriceQuantity
445.5521.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:21

Fundamentals

Market Cap: ₹44.82 Cr
PE Ratio (TTM): 52.09
PB Ratio: 8.31
Industry P/E:52.07
Debt to Equity:0.00
ROE:15.95
EPS (TTM):8.47
Book Value:40.24
Face Value: 1.00

Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue214.87 Cr195.02 Cr173.04 Cr177.47 Cr174.84 Cr
Profit23.21 Cr20.62 Cr18.11 Cr20.34 Cr20.21 Cr
Expense184.26 Cr167.85 Cr149.73 Cr150.98 Cr148.39 Cr
Comprehensive income23.21 Cr20.62 Cr18.10 Cr20.34 Cr20.21 Cr
EPS2.392.131.872.102.09
Gufic Biosciences Limited, headquartered in Mumbai, India, is a leading manufacturer and distributor of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services. With a global presence, the company serves markets in India, Africa, Asia, Europe, Australia, North America, and South America.

The company specializes in the production of APIs and bulk drugs, including antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. It also manufactures a range of lyophilized injections, catering to various segments such as antibiotics, antifungals, cardiac medications, infertility treatments, antivirals, and proton-pump inhibitors.

In addition to pharmaceuticals, Gufic Biosciences Limited offers a diverse portfolio of healthcare products, including spark, criti care, criticare life, and ferticare pharmaceuticals. The company also provides herbal, aesthaderm, gufic stridden, and personal care products.

With a strong focus on quality and innovation, Gufic Biosciences Limited supplies its products to hospital chains and medical facilities worldwide. Since its establishment in 1970, the company has been committed to delivering excellence in the pharmaceutical industry.
Company nameListing dateIndustry NSE symbol BSE symbol
Gufic Biosciences Limited Oct, 2004 Aug, 1985 Pharmaceuticals Pharmaceuticals GUFICBIO GUFICBIO

Shareholding pattern

Oct, 2023 Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022

  • Promoters 
    72.51%
    Public 
    27.49%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    75.00%
    Public 
    25.00%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    75.00%
    Public 
    25.00%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    75.00%
    Public 
    25.00%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    75.00%
    Public 
    25.00%
    Shares held by Employee Trusts 
    0.00%

Gufic Biosciences Limited FAQ's

What is the range of today's stock performance for Gufic Biosciences Limited?

Today's stock performance witnessed a fluctuation from a minimum of 437.50 on the NSE (National Stock Exchange) to a maximum of 457.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 438.45 to a high of 457.45.

What are the 52-week low and high values for Gufic Biosciences Limited?

The stock's performance over the past 52 weeks reveals a low of 277.65 (occurred on 15-Mar-2024) and a high of 504.25 (achieved on 08-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 278.00 (on 04-Jun-2024), and the 52-week high is 501.10 (on 08-Nov-2024).

What was the opening and previous closing prices for Gufic Biosciences Limited?

The stock's performance over the past 52 weeks reveals a low of 277.65 (occurred on 15-Mar-2024) and a high of 504.25 (achieved on 08-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 278.00 (on 04-Jun-2024), and the 52-week high is 501.10 (on 08-Nov-2024).

What is the total volume and traded value for Gufic Biosciences Limited for the day?

The total volume is 1, and the total traded value is 3.69 (₹ Lakhs).

What are the upper and lower circuit limits for Gufic Biosciences Limited?

The upper circuit limit is 529.10, and the lower circuit limit is 352.80.

What is the market cap and PE ratio for Gufic Biosciences Limited?

The market cap is ₹44.82 Cr, and the PE ratio (TTM) is 52.07.

What is the PB ratio, industry P/E, and debt to equity ratio for Gufic Biosciences Limited?

The PB ratio is 11.11, industry P/E is 52.07 , and the debt to equity ratio is 0.00.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Gufic Biosciences Limited?

ROE is 15.95, EPS is 8.47, book value is 40.24

What are the revenue and profit figures for the latest quarter and previous quarters for Gufic Biosciences Limited?

In Sep 2023, Revenue is ₹2148741000.00, and Profit is ₹232096000.00. In Jun 2023, Revenue is ₹1950202000.00, and Profit is ₹206229000.00.

When was Gufic Biosciences Limited listed, and what industry does it belong to?

The company, Gufic Biosciences Limited, was listed in Oct 2004 and belongs to the Pharmaceuticals industry. Its NSE symbol is GUFICBIO.

What is the current shareholding pattern of the Gufic Biosciences Limited?

As of latest available update, promoters hold 72.51%, the public holds 27.49%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
29
online
247
Threads
96
Settings
Back
Top